Published: 5 November 2022
Author(s): Shinya Ikeda, Yugo Yamashita, Takeshi Morimoto, Koh Ono, Takeshi Kimura, COMMAND VTE Registry Investigators
Issue: March 2023
Section: Letter to the Editor

Chronic lung disease (CLD), such as asthma, chronic obstructive pulmonary disease (COPD), and restrictive lung diseases, has been reported to be a moderate risk factor for the development of venous thromboembolism (VTE) [1]. In addition, CLD could have a significant impact on acute mortality, and CLD is included in the simplified Pulmonary Embolism Severity Index (sPESI), which is a prognostic score for short-term mortality [2–5]. However, there is still limited data on the impact of CLD on long-term clinical outcomes in patients with VTE.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.